18.97.14.91
18.97.14.91
close menu
Accredited SCIE SCOPUS
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
( Il Rae Park ) , ( Jun Sung Moon )
This article is 4 pages or less.
* This article cannot be purchased.
×